PCR
CANO

Potrero Capital Research’s Cano Health, Inc. CANO Stock Holding History

Potrero Capital Research’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,884
Closed -$1.96M – 82
2020
Q3 		$1.96M Buy
+1,884
New +$1.97M 0.64% 40

Other funds holding CANO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.24B AUM 137.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Potrero Capital Research's CANO Position: Q4 2020 in Review

Potrero Capital Research sold out of Cano Health, Inc. (CANO) in Q4 2020, closing a stake of 1,884 shares — an estimated $1.96M sold.

Potrero Capital Research first reported a position in CANO in Q3 2020 and held it in 1 quarter. The position peaked at $1.96M in Q3 2020. 81 funds tracked by Wall St. Rank hold CANO as of Q4 2020.

  • Potrero Capital Research reported no remaining Cano Health, Inc. position as of Q4 2020 after selling out during the quarter.
  • Potrero Capital Research sold 1,884 Cano Health, Inc. shares in Q4 2020, an estimated $1.96M.
  • Potrero Capital Research first reported a position in Cano Health, Inc. in Q3 2020 and held it in 1 quarter.
  • Potrero Capital Research's Cano Health, Inc. position peaked at $1.96M in Q3 2020.
  • 81 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2020.

Based on Potrero Capital Research's 13F filing for Q4 2020, filed 16 Feb 2021.